Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Winners of the first-ever Nanomedicine Award revealed at BIO-Europe

Abstract:
The winners of the first ever Nanomedicine Award were officially announced during the Nanomedicine Panel at BIO-Europe conference in Vienna, November 4th 2013. The Award review Board agreed to distinguish two projects: Endomagnetics technology in the nanodiagnostic category and I-CARE project from Linköping University in the regenerative medicine category.

Winners of the first-ever Nanomedicine Award revealed at BIO-Europe

Berlin, Germany | Posted on November 4th, 2013

"We have received a lot of exceptional applications for the Nanomedicine Award, with 23 candidates coming from all over the world and from different horizons and application areas. It has been incredibly hard for the judging committee to select the winners that are excelling in their innovative nanomedicine approaches", said Laurent Levy, chairman of the Award review board and vice-chairman of the ETPN. "It is a great pool of examples to show the true potential of nanomedicine in providing important solutions for currently unmet medical needs and a major opportunity to enhance the synergies of the field with the pharmaceutical industry, a crucial stakeholder in the development of products towards the patients."

The nanodiagnostic Award winning company, Endomagnetics Ltd, is developing advanced magnetic sensing technology to increase access to the standard of care in breast cancer staging by providing an alternative approach to locating sentinel lymph nodes (www.endomagnetics.com).

"Endomagnetics is very honoured to have been selected for an inaugural Nanomedicine Award, particularly given the global candidates and great promise of this convergent industry. This award enhances the medtech facet of nanomedicine and increases our visibility to potential partners as we develop further across the nanomedicine field." said Dr Eric Mayes, CEO of Endomagnetics Ltd.

The jury also decided to award in the regenerative medicine category the candidate Linköping University for the European Project entitled Integrative nano-Composites And Regeneration of the Eye (I-CARE), a regenerative medicine‐based treatment for Corneal Herpes Simplex Keratitis (HSK), that simultaneously treat the disease while regenerating the damaged cornea (www.hu.liu.se/igen/griffith-may?l=en).

"For the I-CARE team, the Nanomedicine Award 2013 is an acknowledgement of our hard work and multidisciplinary approach to successfully extending regenerative medicine approaches to restoring organs that are failing due to immunopathologic causes, in this case, corneas with herpes simplex keratitis, the leading cause of infectious blindness worldwide. We hope that we will successfully bridge the translational gap from clinical need to clinical trials, allowing us to continue to work together and with others within the nanomedicine community in further European projects", said May Griffith, Professor at Linköping University, Department of Clinical and Experimental Medicine.

Award winners benefited from a full registration (including partnering) for BIO-Europe 2013 and presented their application in a 5-minute speech at the Nanomedicine Panel Discussion during the event. In addition, the winners will be granted a 15-minute presentation slot during the CLINAM conference 2014 in Basel, Switzerland, along with 1 year's free ETPN membership and two days consultation by the members of the ETPN Translational Advisory Board for experts' advice and guidance.

####

About ETP Nanomedicine
The European Technology Platform Nanomedicine was established in 2005 as a joint venture of the European Commission and CEOs of large industrial companies, SMEs and academic research institutions to investigate and advance joint activities in the area of nanotechnology in medicine. Since 2005 the ETPN published a number of strategic documents outlining the needs and roadmaps for nanomedicine research in Europe. The ETPN contributed to set up numerous European funded projects providing a first impression of the conditions for a suitable social and economic environment and the structural requirements for an efficient translation of R&D results into innovative nanomedicine. The ETPN supports its members in coordinating their joint research efforts and improving communication amongst the members as well as towards the European Commission and the European Member States.

ABOUT BIO-EUROPE 2013 - www.ebdgroup.com/bioeurope

The 19th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 3,000 global decision makers from biotechnology, pharma and finance, representing upwards of 1,700 companies from over 50 countries, annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe will take place November 4–6, 2013 in Vienna, Austria.

Follow BIO-Europe 2013 on Twitter: twitter.com/ebdgroup (hashtag: #BEU13)

SPONSORS

Nanobiotix - www.nanobiotix.com

Nanobiotix is a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer. The Company’s first-in-class, proprietary technology, NanoXray, enhances radiotherapy energy to provide a new, more efficient treatment for cancer patients. NanoXray products are compatible with current radiotherapy and brachytherapy treatments and are meant to treat a wide variety of cancers via multiple routes of administration. Nanobiotix’s lead product NBTXR3, based on NanoXray, is currently under clinical development for soft tissue sarcoma and for Head and Neck cancers. The Company, based in Paris, France, has partnered with PharmaEngine for clinical development and commercialization of NBTXR3 in Asia.

Nanobiotix is listed on the NYSE Euronext regulated market in Paris (ISIN: FR0011341205, Euronext ticker: NANO, Bloomberg: NANO: FP).

EBD Group- www.ebdgroup.com

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

· BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)

· BioPharm America™, the fastest growing partnering event in North America

· Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors

· BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO

· ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC

· EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry

· Partnering for Global Impact®, a new partnering conference providing an innovative forum to partner, identify and generate social and philanthropic investment and funding opportunities

EBD Group’s sophisticated web-based partnering service, partneringONE®, is also used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences all year long.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

For more information please visit www.ebdgroup.com.

For more information, please click here

Contacts:
Olivier Fontaine
ETPN Secretariat
c/o VDI/VDE Innovation + Technik GmbH
+49 (0)30 310078 155


Erin Righetti
Public Relations Manager
EBD Group
+1 760 930 0500

Copyright © ETP Nanomedicine

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014

Brookhaven Lab Launches Computational Science Initiative:Leveraging computational science expertise and investments across the Laboratory to tackle "big data" challenges October 22nd, 2014

Bipolar Disorder Discovery at the Nano Level: Tiny structures found in brain synapses help scientists better understand disorder October 22nd, 2014

NIST offers electronics industry 2 ways to snoop on self-organizing molecules October 22nd, 2014

Nanomedicine

Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014

Bipolar Disorder Discovery at the Nano Level: Tiny structures found in brain synapses help scientists better understand disorder October 22nd, 2014

Journal Nanotechnology Progress International (JONPI), 2014, Volume 5, Issue 1, pp 1-24 October 22nd, 2014

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Announcements

NanoTechnology for Defense (NT4D) October 22nd, 2014

Mechanism behind nature's sparkles revealed October 22nd, 2014

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Researchers patent a nanofluid that improves heat conductivity October 22nd, 2014

Events/Classes

NanoTechnology for Defense (NT4D) October 22nd, 2014

Ucore's McKenzie to Deliver Presentation to Rare Earths Conference in Singapore as Highlight of Fall 2014 Marketplace Schedule October 19th, 2014

Aspen Aerogels, Inc. Schedules Third Quarter 2014 Earnings Release and Conference Call for November 6, 2014 October 17th, 2014

New VDMA Association "Electronics, Micro and Nano Technologies" founded: Inaugural Meeting in Frankfurt/Main, Germany October 15th, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

Special UO microscope captures defects in nanotubes: University of Oregon chemists provide a detailed view of traps that disrupt energy flow, possibly pointing toward improved charge-carrying devices October 21st, 2014

Crystallizing the DNA nanotechnology dream: Scientists have designed the first large DNA crystals with precisely prescribed depths and complex 3D features, which could create revolutionary nanodevices October 20th, 2014

QD Vision Wins Prestigious Presidential Green Chemistry Challenge Award from the U.S. Environmental Protection Agency October 16th, 2014

Beyond LEDs: Brighter, new energy-saving flat panel lights based on carbon nanotubes - Planar light source using a phosphor screen with highly crystalline single-walled carbon nanotubes (SWCNTs) as field emitters demonstrates its potential for energy-efficient lighting device October 14th, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE